BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 16474912)

  • 1. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases.
    Yoon SS; Kim SH; Gonen M; Heffernan NM; Detwiller KY; Jarnagin WR; D'Angelica M; Blumgart LH; Tanabe KK; Dematteo RP
    Ann Surg Oncol; 2006 Mar; 13(3):353-62. PubMed ID: 16474912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer.
    Osada S; Matsui S; Komori S; Yamada J; Sanada Y; Ihawa A; Tanaka Y; Tokuyama Y; Okumura N; Nonaka K; Hosono Y; Takahashi T; Yamaguchi K; Yoshida K
    Hepatogastroenterology; 2010; 57(97):76-80. PubMed ID: 20422876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
    Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S
    Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
    Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
    Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor.
    de Jong KP; Hoedemakers RM; Fidler V; Bijzet J; Limburg PC; Peeters PM; de Vries EG; Slooff MJ
    Scand J Gastroenterol; 2004 Nov; 39(11):1141-8. PubMed ID: 15545174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases.
    Rahbari NN; Reissfelder C; Mühlbayer M; Weidmann K; Kahlert C; Büchler MW; Weitz J; Koch M
    Ann Surg Oncol; 2011 Aug; 18(8):2182-91. PubMed ID: 21598056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
    Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
    Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased growth factor expression after hepatic and pancreatic resection.
    Justinger C; Schlüter C; Oliviera-Frick V; Kopp B; Rubie C; Schilling MK
    Oncol Rep; 2008 Dec; 20(6):1527-31. PubMed ID: 19020737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity.
    Viganò L; Ferrero A; Lo Tesoriere R; Capussotti L
    Ann Surg Oncol; 2008 Sep; 15(9):2458-64. PubMed ID: 18463927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.
    Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC
    Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic lymphatic invasion independently predicts poor survival and recurrences after hepatectomy in patients with colorectal carcinoma liver metastases.
    Korita PV; Wakai T; Shirai Y; Sakata J; Takizawa K; Cruz PV; Ajioka Y; Hatakeyama K
    Ann Surg Oncol; 2007 Dec; 14(12):3472-80. PubMed ID: 17828431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative detection of circulating cancer cells in patients with colorectal hepatic metastases.
    Uchikura K; Ueno S; Takao S; Miyazono F; Nakashima S; Tokuda K; Nakajo A; Matsumoto M; Aiko T
    Hepatogastroenterology; 2002; 49(48):1611-4. PubMed ID: 12397747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases.
    Bennett JJ; Schmidt CR; Klimstra DS; Grobmyer SR; Ishill NM; D'Angelica M; DeMatteo RP; Fong Y; Blumgart LH; Jarnagin WR
    Ann Surg Oncol; 2008 Apr; 15(4):1130-6. PubMed ID: 18228106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solitary colorectal liver metastasis: resection determines outcome.
    Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
    Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver mestastasis vascularity and volume.
    Davies MM; Jonas SK; Kaur S; Allen-Mersh TG
    Br J Cancer; 2000 Mar; 82(5):1004-8. PubMed ID: 10737380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.
    Shah SA; Haddad R; Al-Sukhni W; Kim RD; Greig PD; Grant DR; Taylor BR; Langer B; Gallinger S; Wei AC
    J Am Coll Surg; 2006 Mar; 202(3):468-75. PubMed ID: 16500252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases.
    Pamecha V; Glantzounis G; Davies N; Fusai G; Sharma D; Davidson B
    Ann Surg Oncol; 2009 May; 16(5):1202-7. PubMed ID: 19130138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management for metastatic liver tumors.
    Hirai I; Kimura W; Fuse A; Isobe H; Hachiya O; Moriya T; Suto K; Mizutani M
    Hepatogastroenterology; 2006; 53(71):757-63. PubMed ID: 17086883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.